BiotechTube
Home/Peptinovo Biopharma/Dr. Bill Elliott, PhD
DB

Dr. Bill Elliott, PhD

Co-Founder, CTO

Peptinovo Biopharma

Therapeutic Areas

Oncology

Peptinovo Biopharma Pipeline

DrugIndicationPhase
PNB-281Solid TumorsPreclinical
PALM™ Tubulin DisruptorsSolid TumorsPreclinical
PALM™ Platinum DrugsSolid TumorsPreclinical
PALM™ GemcitabineSolid TumorsPreclinical

Leadership Team at Peptinovo Biopharma

DR
Dr. Ren Homan, PhD
Founder, CSO
ST
Steve Tokarz, MBA
CEO
DJ
Dr. Jan Van Tornout, MD
Chief Medical Officer
DW
Dr. Wayne Klohs, PhD
Head of Clinical Design & Oncology Strategy
View full Peptinovo Biopharma profile